Literature DB >> 12428491

[Pancreatic metastasis of renal cell carcinoma: report of three cases].

D Béchade1, L Palazzo, J Desramé, C Duvic, M Hérody, F Didelot, G Coutant, J P Algayres.   

Abstract

INTRODUCTION: The pancreas is an uncommon site of metastasis from renal cell carcinoma. EXEGESIS: Three observations are described in this review which is aimed at reporting recent data on diagnosis, prognosis and therapeutic features of this kind of metastasis 0: The average space of time between nephrectomy and the diagnosis of the metastasis was 16 years. They have been fortuitously discovered in 2 cases, in patients who did not complain of any pancreatic symptom, during abdominal ultrasonography done for another reason. In the third case, pancreatic symptoms led to the diagnosis. Endoscopic ultrasonography (EUS) was useful to diagnose multiple lesions misdiagnosed on CT-scan or MRI imaging. EUS patterns are characteristic, but histological and cytological examinations of EUS-guided needle biopsies are difficult to study according to the hypervascularized character of these metastasis.
CONCLUSION: The diagnosis of pancreatic metastasis must be suggested for patients suffering from a pancreatic mass with a previous medical history of late renal cell carcinoma. According to their hypervascularized character, the negativity of EUS-guided needle biopsies could strongly direct the diagnosis. When surgery is possible, the survival rate is better than in primary pancreatic adenocarcinoma and is even better than in pancreatic metastasis from other sites.

Entities:  

Mesh:

Year:  2002        PMID: 12428491     DOI: 10.1016/s0248-8663(02)00693-8

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  8 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

Review 2.  Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?

Authors:  Franz Sellner
Journal:  Clin Exp Metastasis       Date:  2018-06-12       Impact factor: 5.150

3.  Combined resection of the pancreas and inferior vena cava for pancreatic metastasis from renal cell carcinoma.

Authors:  J J Tuech; B Lefebure; V Bridoux; B Albouy; E Lermite; F Le Pessot; I Le Blanc-Louvry; F Michot
Journal:  J Gastrointest Surg       Date:  2007-09-06       Impact factor: 3.452

Review 4.  Pancreatic metastases from renal cell carcinoma: a case report and literature review of the clinical and radiological characteristics.

Authors:  Yoshinori Hoshino; Hiroharu Shinozaki; Yuki Kimura; Yohei Masugi; Homare Ito; Toshiaki Terauchi; Masaru Kimata; Junji Furukawa; Kenji Kobayashi; Yoshiro Ogata
Journal:  World J Surg Oncol       Date:  2013-11-09       Impact factor: 2.754

5.  Diagnosis and treatment of pancreatic metastases in 22 patients: a retrospective study.

Authors:  Shao-Wei Song; Jun-Feng Cheng; Ning Liu; Ting-Han Zhao
Journal:  World J Surg Oncol       Date:  2014-09-25       Impact factor: 2.754

Review 6.  Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism?

Authors:  Franz Sellner
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

Review 7.  Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations.

Authors:  Franz Sellner
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

Review 8.  Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.

Authors:  Franz Sellner; Sabine Thalhammer; Martin Klimpfinger
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.